Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Fjær, Sveinung ^a,b   Bø, Lars ^a,b   Lundervold, Arvid ^a,b   Myhr, Kjell Morten ^a,b   Pavlin, Tina ^a,b   Torkildsen, Øivind ^a,b   Wergeland, Stig ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BRAIN; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FEMALE; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; TIME FACTORS;

EID: 84893576920     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084162     Document Type: Article

References (36)

1. Geurts JJG, Barkhof F (2008) Grey matter pathology in multiple sclerosis. Lancet Neurol 7: 841-851.
2. Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15: 239-245.
3. Hackmack K, Weygandt M, Wuerfel J, Pfueller CF, Bellmann-Strobl J, et al. (2012) Can we overcome the 'clinico-radiological paradox' in multiple sclerosis? J Neurol 259: 2151-2160.
4. Ciccarelli O,Werring DJ,Wheeler-Kingshott CA, Barker GJ, Parker GJ, et al. (2001) Investigation of ms normal-appearing brain using diffusion tensor mri with clinical correlations. Neurology 56: 926-933. (Pubitemid 32290810)
5. Cercignani M, Inglese M, Pagani E, Comi G, Filippi M (2001) Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 22: 952-958. (Pubitemid 32436241)
6. Nijeholt GJ, Bergers E, Kamphorst W, Bot J, Nicolay K, et al. (2001) Post-mortem high-resolution mri of the spinal cord in multiple sclerosis: a correlative study with conventional mri, histopathology and clinical phenotype. Brain 124: 154-166. (Pubitemid 32055997)
7. Vrenken H, Geurts JJG, Knol DL, van Dijk LN, Dattola V, et al. (2006) Whole-brain t1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 240: 811-820. (Pubitemid 44267339)
8. Geurts JJG, Blezer ELA, Vrenken H, van der Toorn A, Castelijns JA, et al. (2008) Does high-field mr imaging improve cortical lesion detection in multiple sclerosis? J Neurol 255: 183-191.
9. Geurts JJG, Pouwels PJW, Uitdehaag BMJ, Polman CH, Barkhof F, et al. (2005) Intracortical lesions in multiple sclerosis: improved detection with 3d double inversion-recovery mr imaging. Radiology 236: 254-260. (Pubitemid 40853320)
10. Wilhelm MJ, Ong HH, Wehrli SL, Li C, Tsai PH, et al. (2012) Direct magnetic resonance detection of myelin and prospects for quantitative imaging of myelin density. Proc Natl Acad Sci U S A 109: 9605-9610.
11. Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, et al. (1992) Experimental aller- gic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 182: 483-491.
12. Filippi M, Rocca MA, Comi G (1998) Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement. J Neurol Sci 159: 162-165. (Pubitemid 28384523)
13. Dousset V, Gayou A, Brochet B, Caille JM (1998) Early structural changes in acute ms lesions assessed by serial magnetization transfer studies. Neurology 51: 1150-1155. (Pubitemid 28473417)
14. Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, et al. (1995) A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45: 478-482.
15. Filippi M, Iannucci G, Tortorella C, Minicucci L, Horsfield MA, et al. (1999) Comparison of ms clinical phenotypes using conventional and magnetization transfer mri. Neurology 52: 588-594. (Pubitemid 29075609)
16. Dehmeshki J, Chard DT, Leary SM, Watt HC, Silver NC, et al. (2003) The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 250: 67-74. (Pubitemid 36206687)
17. Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, et al. (2006) Magnetization transfer mri metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 129: 2620-2627. (Pubitemid 44522095)
18. Vavasour IM, Laule C, Li DKB, Traboulsee AL, MacKay AL (2011) Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? J Magn Reson Imaging 33: 713-718.
19. Merkler D, Boretius S, Stadelmann C, Ernsting T, Michaelis T, et al. (2005) Multicontrast mri of remyelination in the central nervous system. NMR in Biomedicine 18: 395-403. (Pubitemid 41410360)
20. Zaaraoui W, DeloireM, Merle M, Girard C, Raffard G, et al. (2008) Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 t. MAGMA 21: 357-362.
21. Boretius S, Escher A, Dallenga T,Wrzos C, Tammer R, et al. (2012) Assessment of lesion pathology in a new animal model of ms by multiparametric mri and dti. Neuroimage 59: 2678-2688.
22. Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38: 963-974.
23. Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, et al. (2009) Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283: 127-138.
24. Wergeland S, Øivind Torkildsen, Myhr KM, Aksnes L, Mørk SJ, et al. (2011) Dietary vitamin d3 supplements reduce demyelination in the cuprizone model. PLoS One 6: e26262.
25. Aharoni R, Sasson E, Blumenfeld-Katzir T, Eilam R, Sela M, et al. (2012) Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate. Experimental neurology.
26. Rocca MA, Mastronardo G, Rodegher M, Comi G, Filippi M (1999) Long-term changes of magneti- zation transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. AJNR Am J Neuroradiol 20: 821-827. (Pubitemid 29536257)
27. Wergeland S, Øivind Torkildsen, Myhr KM, Mørk SJ, Bø L (2012) The cuprizone model: regional heterogeneity of pathology. APMIS 120: 648-657.
28. Vrenken H, Pouwels PJW, Ropele S, Knol DL, Geurts JJG, et al. (2007) Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and mr measures of disease. Mult Scler 13: 708-716. (Pubitemid 47074092)
29. Sharma J, Zivadinov R, Jaisani Z, Fabiano AJ, Singh B, et al. (2006) A magnetization transfer mri study of deep gray matter involvement in multiple sclerosis. J Neuroimaging 16: 302-310. (Pubitemid 44521379)
30. Seewann A, Kooi EJ, Roosendaal SD, Pouwels PJW, Wattjes MP, et al. (2012) Postmortem veri- fication of ms cortical lesion detection with 3d dir. Neurology 78: 302-308.
31. Minagar A, Barnett MH, Benedict RHB, Pelletier D, Pirko I, et al. (2013) The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology 80: 210-219.
32. Chen JTH, Easley K, Schneider C, Nakamura K, Kidd GJ, et al. (2013) Clinically feasible mtr is sensitive to cortical demyelination in ms. Neurology 80: 246-252.
33. Filippi M, Preziosa P, Copetti M, Riccitelli G, Horsfield MA, et al. (2013) Gray matter damage predicts the accumulation of disability 13 years later in ms. Neurology.
34. Rausch M, Tofts P, Lervik P, Walmsley A, Mir A, et al. (2009) Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f. Mult Scler 15: 16-27.
35. Deloire-Grassin MS, Brochet B, Quesson B, Delalande C, Dousset V, et al. (2000) In vivo evaluation of remyelination in rat brain by magnetization transfer imaging. J Neurol Sci 178: 10-16.
36. Thiessen JD, Zhang Y, Zhang H, Wang L, Buist R, et al. (2013) Quantitative mri and ultrastructural examination of the cuprizone mouse model of demyelination. NMR Biomed 26: 1562-1581.